Suppr超能文献

慢性根性疼痛患者的痛觉过敏与镇痛之间呈负相关:氢吗啡酮治疗是一把双刃剑吗?

A negative correlation between hyperalgesia and analgesia in patients with chronic radicular pain: is hydromorphone therapy a double-edged sword?

机构信息

The Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel; Institute of Pain Medicine, Rambam Health Care Campus, Haifa, Israel.

出版信息

Pain Physician. 2013 Jan;16(1):65-76.

Abstract

BACKGROUND

Opioids are the cornerstone therapy for the treatment of moderate to severe pain. Yet, unconfirmed evidence suggests that chronic exposure to opioids may cause hypersensitivity to pain, a phenomenon known as opioid-induced hyperalgesia (OIH).

OBJECTIVES

The current preliminary prospective study was aimed to explore the relationship between experimental OIH and clinical opioid induced analgesia (OIA) in a model of experimental OIH in patients with chronic radicular pain using intermediate-term opioid therapy.

STUDY DESIGN

Prospective evaluation

SETTING

Interdisciplinary Pain Clinic at a referral Health Care Campus

METHODS

Thirty patients with chronic neuropathic (radicular) pain were assessed prior to and following 4 weeks of an individually titrated dose of oral hydromorphone treatment (4-20 mg/d). The assessments included an evaluation of experimental OIH by testing for heat pain intensity and cold pain tolerance and an assessment of OIA by completing pain and disability questionnaires.

RESULTS

Hydromorphone was found to induce hyperalgesia, as measured by an elevation of phasic heat pain intensity (P < 0.05). At the same time, hydromorphone caused significant clinical analgesic effects. There was a notable reduction in average daily pain scores (primary analgesic outcome) of 26 Visual Analog Scale (0-100) points. A significant negative correlation was found between OIH and all OIA measures (r = -0.389, P < 0.05 for the primary analgesic outcome). Hydromorphone dosage was positively correlated with OIH (P < 0.01, r = 0.467) and negatively correlated with OIA parameters (r = -0.592, P < 0.01 for the primary analgesia outcome).

LIMITATIONS

The nonrandomized, open-label, prospective evaluation.

CONCLUSION

A 4-week regimen of open-label hydromorphone therapy results in a dose-dependent OIH, which negatively correlates with its analgesic effect. Future randomized, controlled, and blinded studies are needed to verify these preliminary results.

摘要

背景

阿片类药物是治疗中重度疼痛的基石疗法。然而,未经证实的证据表明,慢性暴露于阿片类药物可能导致对疼痛的敏感性增加,这种现象称为阿片类药物引起的痛觉过敏(OIH)。

目的

本初步前瞻性研究旨在探讨慢性根性疼痛患者中实验性 OIH 模型中,使用中短期阿片类药物治疗时,实验性 OIH 与临床阿片类药物引起的镇痛(OIA)之间的关系。

研究设计

前瞻性评估

设置

转诊医疗保健园区的跨学科疼痛诊所

方法

30 例慢性神经性(根性)疼痛患者在接受个体化滴定剂量口服氢吗啡酮治疗(4-20mg/d)前和 4 周后进行评估。评估包括通过测试热痛强度和冷痛耐受来评估实验性 OIH,并通过完成疼痛和残疾问卷来评估 OIA。

结果

氢吗啡酮被发现会引起痛觉过敏,表现为相性热痛强度升高(P<0.05)。与此同时,氢吗啡酮引起了显著的临床镇痛效果。平均每日疼痛评分(主要镇痛结果)降低了 26 个视觉模拟量表(0-100)点。OIH 与所有 OIA 测量值之间存在显著负相关(r=-0.389,P<0.05,主要镇痛结果)。氢吗啡酮剂量与 OIH 呈正相关(P<0.01,r=0.467),与 OIA 参数呈负相关(r=-0.592,主要镇痛结果 P<0.01)。

局限性

非随机、开放标签、前瞻性评估。

结论

为期 4 周的开放标签氢吗啡酮治疗方案导致剂量依赖性 OIH,与镇痛效果呈负相关。需要进行随机、对照、双盲研究来验证这些初步结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验